17:23 EST Arcutis Biotherapeutics files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARQT:
- Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference
- Arcutis announces JAAD published results from trial evaluating ZORYVE
- Journal of the American Academy of Dermatology Publishes ZORYVE (roflumilast) Foam, 0.3% Results for Seborrheic Dermatitis from Pivotal Phase 3 Trial
- Arcutis Biotherapeutics announces launch of ZORYVE topical foam in U.S.
- Arcutis Biotherapeutics announces new individual patient response data